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ABSTRACT OF THESIS 
The Skin Disease Mutation Cx31L209F Induces a Calcium- and Cobalt-Sensitive Leak 
Current across the Plasma Membrane 
 
Gap junctions are essential to the function of multicellular animals, which require a high 
degree of coordination between cells. The functions of gap junctions are highly diverse 
and include exchange of metabolites and electrical signals between cells, as well as 
functions apparently unrelated to intercellular communication. In vertebrates, gap 
junctions are comprised of connexin proteins and over 20 connexins have been identified 
in humans.  Each connexin is named according to its predicted molecular weight, for 
instance connexin31 (Cx31) has a predicted molecular weight of 31 KDa.  Mutations in 
connexin genes cause a variety of disorders depending on the connexin protein affected. 
Cx31 is one of the gap junction proteins expressed in skin and the inner ear. Some point 
mutations cause a rare skin disease termed erythrokeratodermia variabilis (EKV) whereas 
other mutations cause non-syndromic hearing loss (NSHL). The main goal of this project 
was to create, express and study Cx31L209F, a hereditary skin disease mutation which 
occurs in the fourth transmembrane domain. Other mutations (S26T, C86S and L135V) 
were also briefly studied.  The L209F mutant induced large membrane currents and 
compromised the health of single cells suggesting that aberrant hemichannel behavior 
may underlie the disease pathology. Cell death in L209F-expressing cells was rescued by 
the addition of 2 mM calcium or 1 mM cobalt, conditions known to block hemichannel 
function. Two of the other mutations S26T, and L135V appeared to form gap junctions 
with altered gating properties.  
   iii 
 
 
Buffalo State College 
State University of New York 
Department of Biology 
 
The Skin Disease Mutation Cx31L209F Induces a Calcium- and Cobalt-Sensitive Leak 
Current across the Cell Membrane  
 
A Thesis in 
Biology 
By 
Husain Awad Bneed 
Submitted in Partial Fullfillment 
Of the Requirements for the Degree of 
Master of Arts 
 
 
 
May 2016 
 
Approved By: 
I. Martha Skerrett, Ph.D. 
Thesis Advisor and Chair of the Committee 
 
I. Martha Skerrett, Ph.D. 
Associate Professor and Chair of Biology 
 
Kevin Railey, Ph.D. 
Dean of the Graduate School 
Associate Provost 
 
 
   iv 
 
 
 
 
 
Thesis Committee 
I. Martha Skerrett, Ph.D. 
Associate Professor of Biology 
Gary W. Pettibone, Ph.D. 
Professor of Biology 
Derek L. Beahm, Ph.D. 
Research Assistant Professor of Biology 
 
 
 
 
 
 
 
 
 
 
 
 
   v 
 
Acknowledgements 
I would like to express my sincere appreciation to my great advisor Dr. Martha Skerrett 
for everything; support, advice, encouragement and supervision for the last two years. 
Without her, this work would have never been finished.  
To the Higher Committee for Education Development in Iraq (HCED), I would like to 
say thank you for giving me this great opportunity to finish my higher education in the 
U.S. and supporting me throughout my study.  
Also I would like to thank my committee members, Dr. Derek Beahm and Dr. Gary 
Pettibone for their advice about this research. 
I would like to thank all the staff in the biology department at Buffalo State for their 
support and encouragement. Also I want to thank all the graduate students in Dr. 
Skerrett’s lab for their help. 
In the end and from deep of my heart, I would like to thank my father, mother, brothers, 
sisters and my lovely wife, Seemaa. I am grateful to everyone of you.  You are my source 
of my inspiration. With your support, I achieved my goal and got my degree successfully.  
 
                                                                      Husian Awad Bneed
vi 
 
TABLE OF CONTENTS 
Abstract………………………………….…………………….….…….………... ii  
Acknowledgments…………………………….……………….…….………....… v 
Table of Content……………………………………………….……….…......…. vi 
List of Figures…….................................................................................................. vii 
Introduction……….................................................................................................. 1 
Methods…………………………..…………….………………...…...…..…….… 7 
                 Primer Design…………………….................................................... 7 
                     Site-Directed Mutagenesis………………….….............................. 8 
                     In Vitro Transcription………………….......................................... 11 
                    Expression in Xenopus Oocytes……….…..………...…….…......... 12 
Results and Discussion………………………….……………….……………........ 13 
        Hydropathy Analysis of L209F………………………...……........ 13 
                      Expression of Cx31L209F Compromises the Health of Oocytes… 14 
                      Cx31L209F May be Capable of Forming Gap Junctions….……... 14 
           Two Other Cx31 Mutants form Gap Junctions with Altered                                
                      Properties……………………………………………………........ 15 
            Unusual Voltage-Dependent Gating of Cx31…………………..…. 17 
           Expression of Cx31L209F Causes Leaky Membranes…………… 18 
                      Further investigation of L209F-expression in single oocytes…….. 19 
                     Oocytes expressing L209F are rescued by calcium and cobalt……. 21 
Conclusion…………………………………………………………………………. 21 
Figures……………………………………………………………………………... 23 
References…………………………………………………………………………. 39  
 
 
 
vii 
 
LIST OF FIGURES 
Figure 1: Connexin topology and gap junction organization ……………….….... 24 
Figure 2: Intracellular channels assembly and connexin life cycle…………….… 25  
Figure 3: Organs where Cx31 is expressed………………………………….….... 26 
Figure 4: TOPO-CT GFP vector…………………………………………….......... 27 
Figure 5: primers sequence……………………………………………………….. 28 
Figure 6: Components of the mutagenesis reaction…………………………….… 29 
Figure 7: Amino acid alignment of Cx31 and the L209F mutant…………….….. 30 
Figure 8: Examples of RNA analyzed by gel electrophoresis ………………..….. 31 
Figure 9: Membrane Topology Prediction Program…………………………........ 32 
Figure 10: Single Oocytes After Injection…………………………………….….. 33 
Figure 11: Gap junction currents recorded from paired oocytes expressing                    
Cx31 and several skin disease mutants…………………………………………… 34 
Figure 12: Membrane currents recorded in single oocytes expressing skin                 
disease mutations………………………………………………………………….. 35 
Figure 13: Survival of single oocytes injected with RNA encoding Cx31 or     
Cx31L209F…………………………………………………………...…………... 36 
Figure 14: The Cx31 mutation L209F induces oocyte death in a time- and    
concentration-dependent manner ……………………………………………..….. 37 
Figure 15: Viability of oocytes expressing the Cx31 mutation L209F is                
enhanced by calcium and cobalt………………………….…………………….… 38
1 
 
Introduction 
 Gap junctions are specialized membrane structures that provide an intercellular 
pathway for the propagation of signals and diffusion of ions and metabolites between 
cells.  They also have functions that are unrelated to transport such as signaling (Alberts 
et al., 2005). The proteins that form gap junctions in vertebrates differ from those that 
form gap junctions in invertebrates.  In vertebrates, gap junctions are formed by 
connexins, whereas invertebrate gap junction proteins are called innexins (Phelan 2005).  
 
Gap Junction Structure 
 Connexin proteins are the major components of vertebrate gap junction channels 
and are arranged to form aqueous pores that connect the cytoplasm of two cells, allowing 
the transfer of ions and small molecules (Saez et al., 2005). Each connexin protein has 
four transmembrane domains, cytoplasmic amino- and carboxyl termini and two 
extracellular loops (Figure 1a). The sequence and structure of the extracellular loops are 
important determinants of docking interactions. Six connexin proteins assemble to form a 
connexon which is also known as a hemichannel. Each gap junction channel is composed 
of two connexons, which connect or “dock” in the extracellular space (Figure 1b). 
Connexons that are composed of the same connexins are referred to as homomeric, while 
connexons of different connexins are called heteromeric. Additionally, gap junction 
channels formed from the same two connexons are referred to as homotypic, whereas gap 
junctions formed from different connexons are referred to heterotypic (Figure 2a). All of 
these interactions create a broad range of properties in the resulting gap junction channels 
(Goodenough and Paul, 2009). 
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The Connexin Family of Proteins  
 In humans, over 20 different connexin proteins are expressed and each is named 
according to its molecular weight (Scott and Kelsell, 2011). Their expression patterns are 
cell specific and are also overlapping.  Connexin interactions occur when multiple 
connexins are expressed in the same cell or in adjacent communicating cells.  Interactions 
may occur in the endoplasmic reticulum, as the connexin is being trafficked through the 
golgi apparatus or when connexons dock to form intercellular channels (Figure 2b). Like 
most integral membrane proteins, connexins are co-translationally inserted into the ER 
(endoplasmic reticulum). Properly folded connexins are expected to pass through the ER-
Golgi intermediate compartment (ERGIC) prior to entering the cis-Golgi network (Figure 
2b). Several studies have revealed that connexins pass through the Golgi apparatus 
(Musil and Goodenough, 1993). However, other studies have reported that Cx26 can 
reach the cell surface via a Golgi-independent pathway (Evans et al., 1999).   
 
Connexin-Related Diseases 
 Connexin mutations cause a variety of disorders depending on the connexin 
protein affected (Scott and Kelsell, 2011). Connexin31 (Cx31), the focus of this study, is 
expressed in skin, inner ear (Figure 3a and b) and peripheral nerves. Mutations are most 
commonly associated with skin disease but may also cause deafness and/or neuropathy in 
humans (Richard et al., 1998; Scott and Kelsell, 2011). This indicates that Cx31 has a 
role in epidermal differentiation, auditory and neuronal function (Unsworth et al., 2007). 
Furthermore, mutations associated with the same condition may be inherited in an 
autosomal dominant pattern (eg. the skin disease mutation Cx31R42P, Richard et al., 
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1998) or a recessive pattern (eg. the skin disease mutation Cx31 L34P, Gottfried et al., 
2002).   
 Mutations associated with skin disorders specifically cause erythrokeratodermia 
variabilis (EKV) which is classified as a rare skin disease causing abnormal and often 
dangerous skin thickening known as hyperkeratosis (Richard et al., 1998; Scott and 
Kelsell, 2011). Mutations that affect the ear cause non-syndromic hearing loss (NSHL) 
(Laird, 2006). NSHL appears to occur when intercellular communication within the 
cochlea is disrupted, altering potassium distribution (Kikuchi et al., 2000).  
 Interestingly, some Cx31mutations cause only skin disease, some cause only 
deafness, while others have widespread effects. For instance, the G12R mutation 
specifically causes EKV (Itin et al., 1998; Diestel et al., 2002) , the mutation V43M 
causes deafness (Oh et al., 2013) and the mutation Del66D is associated with 
sensorineural hearing loss and peripheral neuropathy (López-Bigas et al., 2001). It is 
unlikely that these differences are based solely on the severity of the mutation, and it has 
been postulated that the location of a mutation in relation to specific protein domains 
might be important. For instance, it was postulated that mutations within the extracellular 
loops are more likely to cause skin disease (López-Bigas et al., 2002), while those in 
other parts of the protein cause deafness (Kelsell et al., 1997). While this does not appear 
to be the case, as new mutations within other domains have been identified, it could 
highlight the importance of variable connexin roles in different tissue.   
 Understanding the consequences of a mutation requires an understanding of 
protein synthesis and trafficking, as well as understanding protein structure-function 
relationships. Connexin proteins have a half-life of a few hours and this short lifespan has 
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been well-documented in cultured cells and in tissue (Laird 2006).  Thus, for reasons that 
remain unclear, connexins are pre-programmed to be continually biosynthesized and 
degraded. It has been suggested that the short half-life is related to a requirement for 
rapid regulation of coupling in response to physiological changes (Laird, 2006). The 
oocyte expression system will be used to assess function of Cx31 mutations in this study. 
The oocyte expression system is ideal for characterizing properties of gap junction 
proteins that traffic to the membrane and form channels with aberrant properties. Ideally 
it is used in combination with studies of trafficking and oligomerization, particularly 
when a mutation fails to form channels. 
 
Analysis of Cx31L209F and Other Mutations that Cause Skin Disease 
 The epidermis of the skin is composed primarily of keratinocytes which undergo 
differentiation, leading to the formation of stratum corneum which forms the skin barrier. 
Cx31 is highly expressed in the stratum granulosum which is part of the upper 
differentiating layer of the epidermis (Di et al., 2001). While the majority of experiments 
focused on L209F, several other mutations were also studied including S26T, L135V and 
C86S. The locations of these mutations are highlighted in Figure 1a and a brief summary 
of the literature related to their identification and characterization is summarized below. 
 
Cx31S26T is a poorly studied mutation associated with EKV (Richard et al., 
2000) listed on the Connexin-Deafness Homepage (http://www.crg.es/deafness) 
under “Connexins Causing Other Diseases”.  It involves substitution of threonine 
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for serine at position 26 within the first transmembrane domain. There does not 
appear to be any literature related to its expression and characterization.   
  
Cx31C86S was one of the first Cx31 mutations associated with EKV (Richard et al., 
1998). It involves substitution of serine for cysteine at position 86 within the second 
transmembrane domain. When it was expressed in Hela cells it appeared to induce cell 
death (He et al., 2005).  Cell death did not appear to occur as a result of hemichannel 
formation. Tattersal and colleagues (2009) further identified an upregulation of the 
unfolded protein response (UPR) as a result of ER retention after expression of C86S in 
cells. By using the oocyte expression system, we aim to determine if C86S is capable of 
forming functional gap junction channels and if so, to further assess the properties of 
those channels. 
 
Cx31L135V was identified in a family with the skin disorder EKV (Scott et al., 
2011). This mutation involves an amino acid substitution of valine for leucine at 
position 135. The residue L135 is located at the border between the cytoplasmic 
loop and the third transmembrane domain (Figure 1a). This dominant mutation 
has been expressed in mammalian cells. It appears to traffic to the plasma 
membrane but does not facilitate dye transfer between cells (Rouan et al., 2003; 
Tattersall et al., 2009). This suggests incorrect assembly or altered properties of 
the resulting gap junctions. 
 
Cx31L209F  The Cx31 mutation L209F was identified in a family with EKV and in 
one unrelated sporadic case (Morley et al., 2005). This mutation may have structural 
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and/or functional significance because it occurs at a conserved phenylalanine residue at 
the border of the cytoplasmic carboxyl terminus and fourth transmembrane domain. 
(Morley et al., 2005).  To the best of our knowledge, the L209F mutation has not been 
previously expressed in oocytes or mammalian cultured cells to investigate the functional 
consequences of the mutation. 
 
Expression in Xenopus Oocytes  
 Oocytes were extracted from Xenopus laevis, a frog found in South Africa. These 
cells are primarily used because of their large size and easiness to maintain and are 
considered the most convenient system to study exogenously expressed ion channels 
(Dascal, 1987). Gap junction channels form between oocytes when gap junction proteins 
are expressed and cells are paired together after removal of the vitelline layer (Werner et 
al, 1985). By coupling oocytes and measuring intercellular junctional conductance, 
properties of mutated gap junctions can be compared to the wild type. This study may 
provide insight into the ways Cx31 mutations effect human physiology and eventually 
allow preventative measures for treatment EKV and NSHL. 
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Methods 
Overview 
 The hCx31 gene (GJB3), was obtained as a gift from Dr. David Kelsell (Barts and 
the University College of London).  The gene was transferred to a TOPO-CT GFP vector 
by Shelby Rarick (SUNY Buffalo State).  Important features of this vector include a 
priming site for RNA polymerase, ampicillin resistance sequences, a multiple restriction 
site, and a c-terminal GFP tag (Figure 4).  For our studies, a stop codon was included at 
the end of the Cx31 sequence to prevent GFP-fusion as our goal was to characterize 
properties of mutants rather than study their localization. Site-directed mutagenesis was 
used to create the mutation L209F. The mutations S26T, C86S and L135V were created 
as part of a class project in BIO314 Advanced Cell Biology (Spring 2014). 
 
Primer Design  
 To facilitate sequence-related aspects of the project, a group of programs offered 
through Biology Workbench (San Diego Supercomputer, SDSC) was used.  The human 
Cx31 gene sequence (GJB3) was obtained through NCBI (accession number 
gi_54607054), uploaded as a nucleotide file, and using the Six Frame function of Biology 
Workbench, the longest Open Reading Frame (ORF) was determined. This sequence was 
selected and saved as a translated protein file. 
              In order to design primers for the mutation L209F, the Stratagene Quikchange 
Primer Design software (Agilent Technologies, Santa Clara, CA) was used. The 
adjustment was made at the 209th codon, originally coding for leucine, converting it to 
the codon for phenylalanine. Mutagenic primers were ordered from IDT (Integrated DNA 
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Technologies, Coalville, Iowa) and they were complementary to one another because 
each primer initiates DNA synthesis on a complementary strand of the plasmid. Forward 
and reverse primers (labelled L209Fa and L209Fb, respectively) were 31 nucleotides in 
length and had a Tm of 78.28 ⁰C (Figure5). 
 
Site- Directed Mutagenesis 
 The QuikChange method of mutagenesis was used to create the L209F mutation 
(Quikchange Mutagenesis Kit, Agilent Technologies).  In the first part of the mutagenic 
process, PCR was used in combination with the mutagenic L209F primers to produce 
site-directed mutated DNA. Primers were obtained as lyophilized powder. They were 
reconstituted by adding 100 μl of nuclease-free water. Primers were further diluted by 
mixing 10 μl of primer with 90 μl of nuclease-free water immediately prior to the 
reaction. In order to calculate an appropriate primer concentration and volume for the 
mutagenesis reaction the mass of each primer was obtained from the information 
provided by the primer-synthesis company (IDT, Coralville Iowa). Primer L209Fa was 
reconstituted from a mass of 0.25 mg/ml and L209Fb from a mass of 0.28 mg/ml.  The 
volume of each primer added to the mutagenesis reaction is shown in Figure 6.  The 
reaction also requires 20 ng of template DNA (the plasmid containing Cx31), reaction 
buffer, dinucleotide triphosphates (dNTP mix), and a DNA polymerase (Quikchange 
Lighetning DNA Polymerase, Agilent Technologies, Santa Clara Inc). The polymerase is 
a high fidelity DNA polymerase that extends mutagenic primers during each PCR 
(Polymerase Chain Reaction) cycle. PCR is a temperature-dependent process with three 
key steps. The first step is denaturation at 95⁰C, the second step in annealing at 65⁰C, and 
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the final step is extension at 70⁰C. These processes are facilitated through the use of a 
thermocycler (BIO RAD, Singapore), which is capable of accurately and quickly 
changing temperature and completing 18 cycles in about 90 minutes. Each cycle creates 
mutated Cx31 plasmid DNA using the original DNA as a template.  Unlike amplifying 
PCR reactions, the newly synthesized daughter strands are not used as templates in 
subsequent cycles.  In this application, the daughter strands contain nicks created adjacent 
to the incorporated primers.   
 After the mutagenic thermocycler session, 2µl of DpnI restriction enzyme was 
added. The DpnI restriction enzyme digests methylated DNA leaving new non-
methylated mutant strands intact.  In our case the Dpn-digest involved an accelerated 
enzyme (Fast-Digest Dpn, Agilent Technologies, Santa Clara Inc) and the reaction was 
incubated at 37⁰C for 15 minutes before the DNA was stored at -20⁰C for further analysis 
 The Dpn-digested DNA was used to transform competent cells (XL-10 Gold 
Ultracompetent Cells, Agilent Technologies, Santa Clara). Two microliters of the DpnI –
treated DNA were transferred to a 14 mL tube containing 50 µl of XL-1 super competent 
cells. The contents were swirled gently. The reaction was then heat’ pulsed for 45 
seconds at 42 °C and placed back on ice for 2 minutes. About 500µl of 42⁰C pre-heated 
nutrient broth (SOC- 20 g/L tryptone, 5 g/L yeast extract, 4.8 g/L MgSO4, 3.6 g/L 
dextrose, 0.5g/L NaCl, 0.186 g/L KCl, Agilent Technologies, Santa Clara) was then 
added before placing in a shaking incubator for 1 hour at 37⁰C. Using a sterilized glass 
rod, 250µl of transformed bacteria was spread evenly on each of two plates.  Plates were 
made with LB medium supplemented with ampicillin (10g/l tryptone, 10g/l NaCl, and 
5g/l yeast extract, 100 μg/ml ampicillin) and 1% agar.   The presence of ampicillin 
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facilitates selection of cells carrying our Cx31 plasmid. Plates and then incubated 
overnight at 37°C. The following day single colonies were observed and the plates were 
wrapped in parafilm for storage at 4 °C.  
 Individual colonies were transferred to about 2 ml of LB medium (10g/l tryptone, 
10g/l NaCl, and 5g/l yeast extract, 100 μg/ml ampicillin).  Innoculation was performed 
using the “flame and loop” method. This process was repeated 4 times. Incubated tubes 
were placed in a shaking incubator overnight at 250 RPM and 37⁰C. 
 A glycerol stock was created for each selected colony in preparation for 
identification of a successful mutation. Three tubes were filled with 500µl of glycerol 
each and then 500µl of the three most turbid cultures was transferred to the stock tubes. 
These tubes were carefully labeled L209Fa, b and c to allow association of sequencing 
results. After being mixed, the stock tubes were stored at -80⁰C. 
 The remaining culture was used for plasmid isolation. About 1.5 ml was 
centrifuged at 13,000 rpm in a table top centrifuge, the supernatant discarded and the 
pellet used in a Qiagen miniprep procedure using centrifugation (Qiagen Inc, 
Mississauga, ON).  In the final step, 50 µl of plasmid DNA was eluted in the provided 
elution buffer.   Gel electrophoresis was performed to assess the approximate 
concentration of plasmid DNA. Two microliters of plasmid DNA from each sample was 
mixed with 4 μl of loading dye then samples were loaded on a 1% agarose gel including 
ethidium bromide, alongside 5μl of DNA ladder to estimate concentration (ZipRuler 2, 
Fermentas Inc). Following electrophoresis at 90 mV for 20 minutes, samples were 
visualized under ultraviolet light and concentration was estimated by comparing the 
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intensity of experimental DNA bands to the known bands in the ladder.  After confirming 
that DNA concentration was greater than 20 ng/μl, small volumes were sent to Genscript 
(Piscataway, NJ) for sequence analysis. Sequencing was performed using the Sanger 
sequencing method with T7 primers. Biology Workbench (SDSC) was used for sequence 
analysis. Nucleotide sequences were downloaded from Genscript and translated using 
SixFrame.  Successive alignment of the wtCx31 protein sequence with each mutated 
sequence shows altered nucleotides and sequence accuracy.  All samples gave excellent 
sequencing through the 207th codon and all contained the mutation resulting in an L209F 
substitution.  Figure 7 shows an alignment of one of the L209F samples.  The L29F 
substitution is noted in the last line with a box.  Other than the targeted mutation, and 
some mismatches at the end of the sequence read, the L209F was identical to Cx31. 
 
In Vitro Transcription  
 DNA was linearized with Xba1 to prepare for in Vitro transcription. Xba1 cuts the 
TOPO vector downstream of the Cx31 coding region (Figure 5). Since all three samples 
contained the mutation,  the sample with the highest concentration of plasmid DNA and 
the longest sequence read was chosen.  Double autoclaved microfuge tubes were used for 
this procedure to prevent contamination with RNase enzymes that might affect 
subsequent steps. Ten microliters of DNA was linearized in a reaction that included 10x 
reaction buffer and 2µl of fast digest Xba1 restriction enzyme. The reaction was 
incubated at 37⁰C for 25 minutes. Following linearization, RNA was transcribed in vitro 
using a mMessage mMachine in vitro transcription kit (Applied Biosystems/Ambion, 
Austin TX) and recovered via LiCl precipitation method, after precipitation and 
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reconstitution the RNA was run on a 1% agarose gel alongside an RNA control (RNA 
250, Applied Biosystems, Austin TX).  The results are shown in Figure 8a.   The RNA was 
then diluted to a concentration of 125 ng/μl or 68 ng/μl with nuclease-free water (Applied 
BiosystemsAustin TX) prior to injection.  Diluted samples of the RNA are shown in 
Figure 8b.  Given a typical injection volume of 40 nl, these concentrations result in about 
5 ng and 2.5 ng of RNA per oocyte.   
 
Expression in Xenopus Oocytes  
 Oocytes were surgically removed from Xenopus laevis females and treated with 
collagenase in order to remove the follicle layer. They were cleaned and digested in 
Oocyte Ringers 2 (OR2; 82.5 mM NaCl, 2 mM KCl, 1 mM MgCl2, 5 mM HEPES, pH 
7.4) and maintained in modified Barth’s (MB1) solution (88 mM NaCl, 1 mM KCl, 0.41 
mM CaCl2, 0.82 mM MgSO4, 1 mM MgCl2, 0.33 mM Ca(NO3)2, 20 mM HEPES, pH 
7.4) (Figure 8a). All oocytes used for gap junction studies were pre-injected with 0.1 ng 
of morpholino antisense oligonucleotide directed against Xenopus Cx38 (Gene Tools 
LLC, Philomath, OR). An NanojectII microinjector (Drummond Scientific, Broomall, 
PA) was used to inject the RNA..  RNA was typically injected at a final concentration of 
125 ng/µl (total RNA ~ 5 ng/oocyte).  For single oocyte analysis, oocytes were 
maintained in shallow culture dishes bathed in MB1.  For gap junction studies, the 
vitelline layer was removed and oocytes paired in agar wells (1% agar in MB1) to allow 
intercellular channel formation.  
 For analysis of single oocytes, a two-electrode voltage clamp was used.  For gap 
junction studies two of the same amplifiers (Axopatch200B, Molecular Devices, 
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Sunnyvale CA) were used to create a dual cell two-electrode voltage clamp.  Dual cell 
clamping allowed us to determine junctional conductance and assess voltage-dependence 
of gap junction channels.  One electrode senses voltage in each cell and the other injects 
current to clamp the voltage.  The “clamp” current reflects the membrane conductance. In 
order to acquire and analyze our data, the programs Clampex10 and Clampfit10 
(Molecular Devices, Sunnyvale CA) were used. The program Origin8 (OriginLab, 
Northampton, MA) was used for graphing and statistical analysis. 
 
 
 
Results and Discussion 
Hydropathy Analysis of L209F 
 In membrane proteins, including connexins, large, bulky amino acids tend to 
cluster at the boundaries of membrane-spanning domains (Mall et al., 2001; Maeda et al., 
2009; Brennan et al., 2015) and it has been postulated that inserting or substituting bulky 
side-chains could influence membrane topology (Brennan et al., 2015). Residue L209 is 
located near the cytoplasmic boundary of the fourth transmembrane domain suggesting 
that phenylalanine substitution might alter topology. Topology prediction software is 
readily available and using TMHMM (Krogh et al., 2001, Biology Workbench, SanDiego 
Super Computer) we compared the predicted amino acids contributing to the fourth 
transmembrane domain of Cx31. It was noted that L209F did not influence topology as 
shown in Figure 9.  In both Cx31 and L209F residues 188 through 210 are predicted to lie 
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within the membrane. While this predictive software does not provide definitive evidence 
regarding insertion of transmembrane domains, it should be noted that at least one other 
mutation (eg. R42P) was found to alter the predicted membrane topology providing a 
possible explanation for the abnormal behavior of the resulting channels (John Lang and 
Daniel Abbatoy, Bio314 Class Project). 
 
Expression of Cx31L209F Compromises the Health of Oocytes 
 The main goal of oocyte expression was to determine if L209F was capable for 
forming gap junctions.  The first attempts to express L209F in oocytes were challenging.  
The oocytes typically died before they could be paired and on rare occasion when they 
survived long enough to be paired the pairs died before we could record intercellular 
currents.  Images of oocytes after injection (Figure 10) show the appearance of healthy 
versus unhealthy oocytes.  Healthy oocytes maintain a clear division of pigment, with 
animal (dark colored) and vegetal (light colored) pigments divided by an “equator”.  
Unhealthy oocytes typically lose the clear division of pigmentation prior to bursting and 
release of yolky cytoplasm.   
 
Cx31L209F May be Capable of Forming Gap Junctions 
  We were able to record one set of intercellular currents from paired oocytes 
expressing the mutant L209F (Cx31/L209F) and it appeared that the mutant was able to 
form functional channels.  These results are shown in Figure 11, middle row left image.  
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In contrast to Cx31 (top two sets of traces) the pair involving L209F did not exhibit 
voltage-dependent inactivation.  The lack of voltage-dependence may indicate that these 
currents are not really representative of gap junctions. Intercellular currents that lack 
voltage sensitivity often reflect membrane fusion.  Another issue with the traces is that 
both sides of the junction lack voltage sensitivity.  A more typical result for a mutation 
that disrupted voltage sensitivity would be an asymmetric set of junctional currents with 
gating at least retained on the wild-type side.  In summary, although L209F induced 
intercellular currents between oocytes, there is little evidence to suggest that gap junction 
channels were responsible. It is more likely that membrane fusion occurred which would 
be consistent with observation that oocyte health was compromised by the oocytes.  
Further studies of paired oocytes are needed to confirm or refute the ability of L209F to 
form gap junctions. These may be possible using new evidence shown below indicating 
that calcium and cobalt can be added to the media to enhance viability of L209F-
expressing oocytes.   
 
Two Other Cx31 Mutants form Gap Junctions with Altered Properties  
 Two other Cx31 mutants were expressed in oocytes and formed gap junction 
channels.  These include L135V and S26T (Figure 11, middle row right and bottom row 
left respectively) which both formed gap junctions with aberrant gating properties.  The 
voltage sensitive properties of these mutants can be compared with Cx31/Cx31 channels 
(top row).  In both cases the mutants were paired heterotypically with wildtype Cx31 and 
asymmetric currents were observed. In these preliminary experiments we did not note 
16 
 
orientation of the paired oocyte so we cannot definitively assign specific gating properties 
to the mutants. However it is most likely that the oocyte displaying the voltage-dependent 
inactivation is the Cx31-expressing oocyte.  For both mutants, one of the oocytes is 
expressing gap junction channels that activate (rather than inactivate) in response to 
voltage.  This is apparent as a slight increase in outward current at higher voltages (note 
that this is the opposite response to wild-type connexins).   
Changes in voltage sensitivity suggest that structural rearrangements have 
occurred within the regions of the protein responsible for sensing voltage and/or gating.  
For connexins in general, there is evidence that the transjunctional voltage (Vj) sensor 
lies within the amino terminal domain (Verselis et al., 1994; Harris 2001) and that gating 
in response to Vj occurs as a result of global rearrangements of transmembrane domains 
(Skerrett et al., 1999; Harris 2001; Brennan et al., 2015). Our results suggest that S26T, 
may cause the channel to remain partially closed at rest, but open in response to Vj.  
Similar observations have been made for a number of connexin mutations including 
several that are associated with disease.  For instance Cx26M34T is one of the most 
prevalent deafness mutations and it also induces a reversal in gating response (Skerrett et 
al., 2004).  The mutation L135V has a similar but less dramatic effect on channel 
properties.  At rest, the channels appear to be open but conductance increases with higher 
Vj.  Further studies are required to confirm the results that Cx31S26T and Cx31L135V 
form gap junction channels with aberrant properties.  
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Unusual Voltage-Dependent Gating of Cx31 
 There is very little published information related to electrophysiological analysis 
of Cx31 (Abrams et al., 2006) and nothing published so far regarding expression of Cx31 
in oocytes.  While analyzing the behavior of wtCx31 in oocyte pairs it was noted that the 
responses in my experiments (Figure 11) are very similar to those of other students 
(Shelby Rarick, Honors Thesis; Shahd Kadhim, MA Thesis) that have expressed Cx31 in 
oocytes. Connexins vary greatly in their sensitivity to Vj, and Cx31 appears to be one of 
the least sensitive (Abrams et al., 2006; Harris, 2001). Direct comparison of the time-
course of inactivation are possible by fitting an exponential curve to the data and 
obtaining a time constant of inactivation at a particular voltage. This analysis is ongoing 
and requires additional data that includes longer pulse lengths than those employed in this 
study.  An interesting observation made while attempting to record longer pulses revealed 
that longer pulses (eg. 5- 20 seconds) induced subsequent decreases in conductance.  This 
suggests that the channels are not fully recovering after they close in response to voltage.  
Similar observations were made by Shahd Kadhim (2015) while working on her Master’s 
thesis in our lab.  When high Vj was applied, even after recovery times up to 5 minutes, 
gap junction conductance did not recover.  This is very unusual as gap junction channels 
composed of most connexins gate to the maximum extent within a few seconds and then 
recover fully within seconds.  A detailed analysis of Vj sensitivity in wtCx31 is ongoing. 
In this study Cx31 Vj-recovery was briefly investigated using a pulse protocol 
involving repeated pulses to 100 mV, followed by a variable recovery period prior to a Vj 
pulse to 100 mV in the opposite polarity.  If the channels recover between the 100 and -
100 mV pulses the magnitude of the current should be the same in the recovery pulse as 
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in the original pulse.  A similar pulse protocol is used to test recovery from inactivation 
in voltage gated sodium and potassium channels (Landowne, 2006). When this pulse 
protocol was applied to Cx31 (Figure 11 bottom right) with each pulse to 100 mV the 
recovery current became smaller regardless of the time allowed for recovery. This 
suggests that Cx31 may possess a gating mechanism that is unique amongst the 
connexins and identifies an added consideration for assessing voltage sensitivity of Cx31 
mutants. 
 
Expression of Cx31L209F Causes Leaky Membranes 
 In order to further study the mechanism by which expression of L209F reduced 
oocyte viability we measured membrane currents in single oocytes expressing L209F. 
The results are shown in Figure 12. Single oocyte voltage clamp was used to pulse 
oocytes between -160 mV and 60 mV. Expression of Cx31 caused very little change in 
membrane properties from that of the negative control (compare filled squares and filled 
triangles). The “oligo” control involved injection of an antisense morpholino, pre-injected 
to reduce expression of endogenous XeCx38. All oocytes receive this “oligo” injection 
prior to injection of connexin RNA. Figure 12 also shows currents induced by two other 
mutants C86S and L135V which cause very mild changes in the current levels.  Work by 
future students will focus on expression of these mutants in other batches of oocytes and 
the significance of these minor changes in current will be assessed. However, L209F 
induces very large leak currents. These currents saturate the capability of the voltage 
clamp outside the range of -40 to +40 mV producing the S-shaped current versus voltage 
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curve.  Most important is the region where current is accurately reflected (-40 mV to 40 
mV) where L209F is strikingly different than Cx31 or other mutants.  
 The observation that L209F induces leak currents in oocytes is indicative of 
altered regulation of hemichannel (connexon) activity.  Prior to docking, connexons must 
be regulated to prevent ions and metabolites from leaking across the membrane of the cell 
prior to gap junction formation.  This is in part carried out by a “loop gate” at the 
extracellular end of the first transmembrane domain (Harris 2001; Verselis et al., 2009).  
Altered hemichannel behavior is unfolding as a key mechanism in connexin-associated 
disease (Martin and van Steensel, 2015; Lilly et al., 2016).  In particular several of the 
connexins expressed in skin and ear have hereditary mutations associated with disease 
and aberrant hemichannel activity (Garcia et al., 2015; Lilly et al., 2016).  This is the first 
observation that Cx31L209F is a mutation that induces aberrant hemichannel behavior 
and is a plausible explanation for the effects of L209F in terms of skin disease.  Targeting 
aberrant hemichannel activity with blockers may provide therapeutic relief for symptoms 
of skin disease.   
Further investigation of L209F-expression in single oocytes. 
 To better understand aspects of L209F-mediated cell death we investigated the 
effect of RNA concentration and the time-course of cell death. As expected, there was a 
strong correlation between the amount of RNA injected and the viability of oocytes one 
day post-injection.  For all the experiments described thus far, oocytes were injected with 
about 5 ng of RNA (injection volume = 41 nl, RNA concentration ≈ 125 ng/µl), a 
quantity that is thought to be optimal for the expression of wtCx31.   
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Figure 13 summarizes the association between RNA levels and cell viability for 
one batch of oocytes. RNA dilutions were made so that full strength equaled 125 ng/µl, ½ 
strength equaled 68 ng/µl and ¼ strength equaled 34 ng/µl. Cx31 was tested at full and 
half strength. L209F was tested at full, one-half and one-quarter strength. For this 
particular batch about 85% of uninjected oocytes survived, about 65% of Cx31 (full-
strength) and about 52% of L209F (full-strength) survived. Viability increased to almost 
control levels in the ½ strength Cx31 group and the ¼ strength L209F group. Although 
survival rates varied between batches of oocytes similar patterns were observed in other 
groups of cells.   
The correlation between RNA quantity and survival is consistent with a 
hemichannel-induced mechanism of cell death.  A hemichannel-related mechanism of 
cell death would also be consistent with more rapid decline in oocyte health when higher 
numbers of channels are formed.  The time-course of cell death is plotted in Figure 14 for 
oocytes injected with varying amounts of L209F RNA.  Oocytes injected with RNA 
encoding Cx31 survived for at least 48 hours after injection (open circles).  In this 
wildtype group, even after 66 hours almost half of the oocytes were still alive.  In 
contrast, less than 10% of oocytes injected with L209F (125 ng/µl) were alive after 40 
hours.  Overall there was a strong correlation between the amount of L209F RNA 
injected and the survival of the oocytes.   
Oocytes expressing L209F are rescued by calcium and cobalt 
 Some connexins that naturally form hemichannels (eg. Cx50) are regulated by 
external calcium concentration (Harris 2001; Ebihara 2003).  Mild increases, for instance 
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1 mM, in external calcium reduce the magnitude of connexin-dependent membrane 
currents (Harris 2001).  For this reason, regulation of membrane currents by calcium is 
often viewed as evidence of hemichannel behavior, most often to investigate the behavior 
of wildtype connexins (Harris, 2001).  Less frequently, cobalt is also used (Malchow et 
al., 1993).  Both calcium (2 mM) and cobalt (1 mM) enhanced the survival of L209F-
expressing oocytes.  Both ions were added to the MB1 solution as chloride salts 
immediately after oocytes were injected with connexin RNA.  Aboout 40 hours after 
injection about 12% of L209F-expressing oocytes whereas about 60% and 80% were 
alive in the calcium and cobalt containing media respectively.  Figure 15 summarizes the 
effect of calcium and cobalt on oocyte viability.  The strongest effect was observed with 
cobalt which boosted survival to 66 hours post-injection from 6% to 72%.   
 
Conclusion 
Overall the results suggest that L209F induces a calcium- and cobalt-sensitive 
leak current when expressed in oocytes.  Membrane currents in L209F-expressing 
oocytes were several orders of magnitude greater than those of Cx31 and two other 
mutants. The leaky membranes were correlated with low survival of L209F-injected 
oocytes.  Survival was enhanced by inclusion of 2 mM CaCl2 or 1 mM CoCl2 in the 
media surrounding the cells, consistent with aberrant hemichannel behavior.  The 
effectiveness of calcium and cobalt in enhancing viability of L209F-expressing oocytes 
presents new avenues in the pursuit of therapeutic strategies in individuals suffering from 
22 
 
skin disease.  Many questions remain including the question of whether Cx31L209F 
interacts with other connexins that are coexpressed in skin.    
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Figure 1 
 
 
A                    B 
                                                                                                                                             
 
Figure 1. Connexin topology and gap junction organization. (A) Membrane topology of a 
typical connexin. Each connexin includes four transmembrane domains (M1-M4), two 
extracellular loops (E1and E2), a cytoplasmic loop (CL), and cytoplasmic amino and 
carboxyl domains. The location of mutations studied are indicated with arrows. (B) Gap 
junction channels are formed by the docking of two hemichannels (connexons), which 
together form a continuous aqueous pore linking the cytoplasm of the two cells. Each 
connexon is composed of six connexin proteins arranged around a central pore (Cook and 
Becker, 2009). 
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Figure 2 
A                                                                                                         B 
 
 
 
 
Figure 2. Cellular organization of connexins.  (A) Arrangement of connexins into various 
channel types. Homomeric channels occur when one type of connexin makes up a 
connexon and heteromeric channels occur when different connexins make up a connexon. 
Docking of connexons results in either homotypic or heterotypic gap junction channels 
(Mathias et al., 2010). (B) Connexin life cycle within a cell.  A connexin protein begins 
its life cycle when it is cotranslationally inserted into the endoplasmic reticulum.  On 
trafficking to the Golgi apparatus it undergoes oligomerization. After microtubule-
facilitated transport to the cell surface, the connexon can dock with connexon 
counterparts from an adhered neighboring cell to form gap junction channels that 
aggregate with other channels constituting the mature gap junction or gap junction plaque 
(Laird, 2006). 
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Figure 3 
A                                                          
 
B 
 
Figure 3.  Organs where Cx31 is expressed (A) The epidermis is composed of four layers 
in thin skin: stratum basale, stratum spinosum, stratum granulosum, and stratum 
corneum. Several connexins are expressed in specific and overlapping patterns. Cx31 
(green) is expressed in the statum granulosum and upper levels of the stratum 
spinulosum. Like Cx31, Cx37 (brown) is expressed in both the statum granulosum and 
stratum spinosum. Cx43 (red) and Cx31.1 (purple) are expressed in the stratum spinosum 
and stratum basale. Cx40 (blue) is restricted to the stratum basale. Cx30 and Cx26 (both 
in yellow) localize to various epidermal layers of epidermis (Churko and Laird, 2013). 
(B) Connexins are expressed in the inner ear where they play a role in development and 
distribution of potassium ions in the cochlea. Nonsensory epithelial cells indicated in 
pink express Cx26 and Cx30, while fibrocytes express Cx31 (Mammano et al., 2007).  
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Figure 4 
 
 
 
 
Figure 4. The gene encoding human Cx31 (GJB3) was inserted into a TOPO GFP fusion 
plasmid (Thermoscientific, Grand Island NY). The gene was inserted so that the T7 
polymerase could be used to synthesize sense RNA. The Cx31 gene included a STOP 
codon and the GFP fusion did not occur. The GFP tag will be used for future studies 
involving expression in mammalian cell lines. The restriction enzyme Xbal was used to 
linearize the DNA prior to in vitro transcription. 
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Figure 5 
 
 
Figure 5. Using the Quikchange Primer Design Program on the stratagene.com website, 
the human Cx31 gene sequence was modified to incorporate a mutation in the 209th 
codon resulting in the substitution L209F.  Each primers is 31 bases in length with a Tm 
of 78.98⁰C.  The primers are complementary to one another to facilitate the mutation on 
opposite strands of the Cx31 sequence.   
 
 
 
 
 
 
 
   
     Primer Name                       Length (nt.)                    Tm                     
 
      L209Fa                                                31                            78.98⁰C                                            
      L209Fb                                                31                             78.98⁰C                
      
 Primer-template duplexes:  
 
                     Primer Name                                                                    Primer-Template Duplex 
                                                 a t c t g t g a g c t c t g c t a c c t c a t c t g c c a c a g g g t c c  
      L209Fba            | | | | | | | | | | | | | | |  | | | | | | | | | | | | | | |  
                   3 ' - a c a c t c g a g a c g a t g a a g t a g a c g g t g t c c c - 5 '
  
                                             5 ' - t g t g a g c t c t g c t a c t t c a t c t g c c a c a g g g 3 '  
      L209Fb             | | | | | | | | | | | | | | |  | | | | | | | | | | | | | | |  
                   t a g a c a c t c g a g a c g a t g g a g t a g a c g g t g t c c c a g g  
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Figure 6 
 
   
 5 µl of 10X reaction buffer 
 2.5 µl of DNA plasmid (20 ng) 
 5 µl of primer #A 
 4.5 µl of primer #B 
 1 µl of dNTP mix 
 30.5 µl of ddH2O to bring up to volume of 50 µl   
___________________________________ 
          50 µl total in reaction 
+      1 µl of Quikchange Lightening DNA polymerase 
 
 
 
Figure 6. Components of the mutagenesis reaction. The reaction was assembled in a 500 
µl thin-walled PCR tube in the order listed. One microliter of Quickchange lightening 
enzyme was added just prior to PCR.  
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Figure 7 
 
 
 
Figure 7.  Amino acid alignment of Cx31 (top) and the L209F mutant. The human Cx31 
gene sequence was retrieved from Genbank (accession # gi 54607054) and translated 
using the “Sixframe” function on Biology Workbench (SanDiego Supercompter, SDSC). 
The mutant sequence was retrieved from Genscript (Piscataway, NJ) after plasmid DNA 
was sequenced in Genscript’s sequencing facility. This sequence was translated using 
Sixframe and aligned with wildtype Cx31 amino acid sequence using ClustalW. 
Successful mutagenesis was confirmed by the change in leucine at position 209 to 
phenylalanine as indicated with the black box. 
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Figure 8 
A 
                        
B  
                                
 
 
 
 
 
 
 
Figure 8. Examples of RNA analyzed by gel electrophoresis.  Gels included 1% agarose 
in TAE and were run for approximately 20 minutes at 120V.  (A) The in vitro 
transcription reaction for Cx31L209F was successful, generating about 1 µg/µl of RNA.   
(B)  To assess the relationship between RNA and physiological effects of L209F, RNA 
was diluted.  Diluting the RNA 250 CONTROL by half resulted in a decrease in band 
intensity (RNA 250 diluted to 125 ng/µl) which correlated well with the intensity of 
L209F (125 ng/µl).  The subsequent dilution of L209F by one-half resulted in a further 
decrease in band intensity.     
ZipRuler RNA 250 
250 ng/µl 
RNA 250  
diluted 125 
ng/µl 
L209F 
125 ng/µl 
L209F 
68ng/µl 
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 Figure 9 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9. The membrane protein topology prediction program TMHMM (Krogh et al., 
2001) was used to assess potential changes in insertion of the fourth transmembrane 
domain due to the L209F substitution in Cx31.  The program predicted that residues 188 
through 210 span the lipid bilayer in both wtCx31 and Cx31L209F.   
 
 
 
 
 
Cx31  
L209F  
TMHMM 
predicted no change in 
TM4 topology as a 
result of  
phenylalanine  
substitution at 
position 209 
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Figure 10 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 10.  Images of Xenopus oocytes expressing connexins. Photographs were 
obtained using a typical digital camera through the lens of a dissecting microscope.  
Oocytes are about 1 mm in diameter.  After injection with RNA encoding L209F, oocytes 
become turgid, the clear division between animal and vegetal pole was lost (center image, 
middle oocyte) and oocytes eventually progressed to bursting (right image). Once the 
oocytes burst the yolky cytoplasm is released into the surrounding media and often pools 
around the oocytes.   
 
 
 
 
Single Oocytes After Injection 
All alive  Some dead All dead 
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Figure 11 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 11. Gap junction currents recorded from paired oocytes expressing Cx31 and 
several skin disease mutants. For the first five sets of currents, cells were clamped at -20 
mV and currents were recorded from this clamped cell while its partner was pulsed in 10 
mV increments to induce transjunctional voltages (Vj’s) between 100 mV and + 100 mV.  
In the last figure, recovery from inactivation was tested by repeatedly inducing a Vj of 
+100 mV for 4 seconds, followed by a variable recovery period and a short pulse to -100 
mV.   
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Figure 12 
 
 
 
 
 
Figure 12. Membrane currents recorded in single oocytes expressing skin disease 
mutations Cx31 L135V, Cx31C86S and Cx31 L209F and oligo injected oocytes as a 
negative control. Oocytes were continuously clamped at -40 mV and pulsed in 20 mV 
increments to -140 and +40 mV.   Voltage steps were 500 milliseconds in length and 
currents were measured at the end of the voltage pulse.   
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Figure 13 
 
 
 
 
Figure 13. Survival of single oocytes injected with RNA encoding Cx31 or Cx31L209F.  
Full strength ≈ 125 ng/µl;  ½ strength ≈  68 ng/µl;  ¼ strength ≈ 34 ng/µl.  
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Figure 14 
 
 
 
 
 
Figure 14.  The Cx31 mutation L209F induces oocyte death in a time- and concentration-
dependent manner. Oocytes were injected with either Cx31 RNA (125 ng/µl) or L209F 
FULL strength (125 ng/µl), HALF strength (68 ng/µl) or QUARTER strength (34 ng/µl).  
At each time point the number of surviving oocytes was counted and recorded.  
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Figure 15 
 
 
Figure 15.  Viability of oocytes expressing the Cx31 mutation L209F is enhanced by 
calcium and cobalt. Oocytes were injected with either Cx31 RNA (125 ng/µl) or L209F 
RNA (125 ng/µl).  Calcium (2 mM CaCl2) and cobalt (1 mM CoCl2) were added to the 
media immediately after injection.  At each time point the number of surviving oocytes 
was counted and recorded.  
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